Plasma Vitamin D-Binding Protein and Risk of Heart Failure in Male Physicians

      Previous studies have suggested that vitamin D deficiency might contribute to the pathogenesis of heart failure (HF); however, limited data are available on the association of vitamin D-binding protein (VDBP)—a major transport protein for vitamin D—and the development of HF. Thus, we investigated whether plasma VDBP is inversely associated with HF risk. Using a prospective nested case-control design, we selected 464 cases and 464 matched controls from the Physicians' Health Study for the present analyses. VDBP was determined using an enzyme-linked immunoassay. Self-reported HF was obtained through annual follow-up questionnaires and validated in a subsample by a review of the medical records. We used conditional logistic regression analyses to compute the adjusted odds ratios. The mean age was 58.6 years, and the median VDBP was 307.8 μg/ml (interquartile range 265.2 to 354.6). Plasma VDBP was not associated with HF in our study. Across the consecutive quintiles of VDBP, the odds ratio was 1.0 (95% confidence interval [CI] reference), 1.05 (95% CI 0.66 to 1.65), 1.28 (95% CI 0.80 to 2.06), 1.07 (95% CI 0.65 to 1.75), and 1.28 (95% CI 0.76 to 2.15); p for linear trend = 0.41, after adjustment for matching factors, body mass index, diabetes, atrial fibrillation, hypertension, and high-sensitivity C-reactive protein. In conclusion, our data have shown no significant association between the plasma levels of VDBP and HF risk in apparently healthy male physicians.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lloyd-Jones D.M.
        • Larson M.G.
        • Leip E.P.
        • Beiser A.
        • D'Agostino R.B.
        • Kannel W.B.
        • Murabito J.M.
        • Vasan R.S.
        • Benjamin E.J.
        • Levy D.
        Lifetime risk for developing congestive heart failure: the Framingham Heart Study.
        Circulation. 2002; 106: 3068-3072
        • Shahar E.
        • Lee S.
        • Kim J.
        • Duval S.
        • Barber C.
        • Luepker R.V.
        Hospitalized heart failure: rates and long-term mortality.
        J Card Fail. 2004; 10: 374-379
        • Goldberg R.J.
        • Spencer F.A.
        • Farmer C.
        • Meyer T.E.
        • Pezzella S.
        Incidence and hospital death rates associated with heart failure: a community-wide perspective.
        Am J Med. 2005; 118: 728-734
        • Goldberg R.J.
        • Glatfelter K.
        • Burbank-Schmidt E.
        • Farmer C.
        • Spencer F.A.
        • Meyer T.
        Trends in mortality attributed to heart failure in Worcester, Massachusetts, 1992 to 2001.
        Am J Cardiol. 2005; 95: 1324-1328
        • Anderson J.L.
        • May H.T.
        • Horne B.D.
        • Bair T.L.
        • Hall N.L.
        • Carlquist J.F.
        • Lappé D.L.
        • Muhlestein J.B.
        Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population.
        Am J Cardiol. 2010; 106: 963-968
        • Zittermann A.
        • Schleithoff S.S.
        • Koerfer R.
        Vitamin D insufficiency in congestive heart failure: why and what to do about it?.
        Heart Fail Rev. 2006; 11: 25-33
        • Patel R.
        • Rizvi A.A.
        Vitamin D deficiency in patients with congestive heart failure: mechanisms, manifestations, and management.
        South Med J. 2011; 104: 325-330
        • Zittermann A.
        • Schleithoff S.S.
        • Tenderich G.
        • Berthold H.K.
        • Körfer R.
        • Stehle P.
        Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?.
        J Am Coll Cardiol. 2003; 41: 105-112
        • Witham M.D.
        Vitamin D in chronic heart failure.
        Curr Heart Fail Rep. 2011; 8: 123-130
        • Witham M.D.
        • Crighton L.J.
        • Gillespie N.D.
        • Struthers A.D.
        • McMurdo M.E.
        The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial.
        Circ Heart Fail. 2010; 3: 195-201
        • Gotsman I.
        • Shauer A.
        • Zwas D.R.
        • Hellman Y.
        • Keren A.
        • Lotan C.
        • Admon D.
        Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome.
        Eur J Heart Fail. 2012; 14: 357-366
        • Schleithoff S.S.
        • Zittermann A.
        • Tenderich G.
        • Berthold H.K.
        • Stehle P.
        • Koerfer R.
        Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial.
        Am J Clin Nutr. 2006; 83: 754-759
        • White P.
        • Cooke N.
        The multifunctional properties and characteristics of vitamin D-binding protein.
        Trends Endocrinol Metab. 2000; 11: 320-327
        • Reid I.R.
        • Bolland M.J.
        Role of vitamin D deficiency in cardiovascular disease.
        Heart. 2012; 98: 609-614
        • Verboven C.
        • Rabijns A.
        • De Maeyer M.
        • Van Baelen H.
        • Bouillon R.
        • De Ranter C.
        A structural basis for the unique binding features of the human vitamin D-binding protein.
        Nat Struct Biol. 2002; 9: 131-136
        • Brandenburg V.M.
        • Vervloet M.G.
        • Marx N.
        The role of vitamin D in cardiovascular disease: from present evidence to future perspectives.
        Atherosclerosis. 2012; 225: 253-263
        • Christakos S.
        • Ajibade D.V.
        • Dhawan P.
        • Fechner A.J.
        • Mady L.J.
        Vitamin D: metabolism.
        Endocrinol Metab Clin North Am. 2010; 39: 243-253
        • Steering Committee of the Physicians' Health Study Research Group
        Final report on the aspirin component of the ongoing Physicians' Health Study.
        N Engl J Med. 1989; 321: 129-135
        • Ho K.K.
        • Anderson K.M.
        • Kannel W.B.
        • Grossman W.L.
        • Levy D.
        Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
        Circulation. 1993; 88: 107-115
        • Djousse L.
        • Gaziano J.M.
        Alcohol consumption and risk of heart failure in the Physicians' Health Study I.
        Circulation. 2007; 115: 34-39
        • Pilz S.
        • Maerz W.
        • Wellnitz B.
        • Seelhorst U.
        • Fahrleitner-Pammer A.
        • Dimai H.P.
        • Boehm B.O.
        • Dobnig H.
        Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.
        J Clin Endocrinol Metab. 2008; 93: 3927-3935
        • Djousse L.
        • Driver J.A.
        • Gaziano M.J.
        Relation between modifiable lifestyle factors and lifetime risk of heart failure.
        JAMA. 2009; 302: 394-400